Sudarshan Pharma Industries Ltd Intrinsic Value
SUDARSHAN · Chemicals · Current price ₹39.49
Is Sudarshan Pharma Industries Ltd undervalued?
DocStoX estimates the fair value of Sudarshan Pharma Industries Ltd at ₹65 per share, versus the current market price of ₹39. That puts the stock about +64.7% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹7), Relative P/E (₹215), Graham floor (₹27). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹7 (bear) to ₹65 (base) to ₹215 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹39 versus an intrinsic value of ₹65, Sudarshan Pharma Industries Ltd currently offers +64.7% of margin.
More on Sudarshan Pharma Industries Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.